查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2073674

容器密封測試市場：按材料、技術、包裝類型、服務類型、最終用戶、應用、國家和地區分類－全球產業分析、市場規模、市場佔有率及2026年至2033年預測

Container Closure Integrity Testing Market, By Material, By Technology, By Packaging Type, By Service Type, By End-user, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2026-2033
出版日期: | 出版商: AnalystView Market Insights | 英文 325 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2025 年，容器密封完整性測試 (CCIT) 市值將達到 2.801 億美元，從 2026 年到 2033 年將以 10.2% 的複合年成長率成長。

容器密封完整性測試 (CCIT) 市場涵蓋用於檢驗藥品和生物製藥包裝完整性的設備、測試技術和驗證服務，確保無菌產品在其保存期限內保持無洩漏和無污染狀態。市場成長的促進因素包括日益嚴格的監管要求、注射和生物製藥產量的不斷成長，以及對產品品質和病患安全日益成長的關注。確定性無損檢測方法、自動化和先進測試系統的日益普及進一步加速了市場需求。然而，高昂的設備成本和複雜的驗證要求仍然限制了市場更廣泛的滲透。

容器和密封完整性測試市場 - 市場動態

無菌注射劑和生物製藥產量增加

推動容器和密封完整性檢測 (CCIT) 市場成長的主要因素之一是無菌注射劑、生物製藥、疫苗和先進療法的產量不斷增加。隨著無菌注射劑和生技藥品的進一步發展，製藥公司越來越重視產品容器和密封件在生命週期各個階段的完整性，並為此投入大量精力，以維持產品無菌狀態，防止微生物和水分污染。美國食品藥物管理局(FDA) 和美國藥典 (USP<1207>) 等機構已製定了無菌產品容器和密封件完整性檢測的監管要求。因此，確定性 CCIT（容器和密封件完整性檢測）方法的市場正在迅速擴張。目前，全球企業生產和提供超過 80 種 CCIT 技術品牌和 40 多種 CCIT 專項服務。除了生技藥品、預填充式注射器和注射療法的持續成長外，日益嚴格的監管將繼續推動對先進的容器和密封完整性測試解決方案的需求。

容器和密封完整性測試市場—市場細分分析：

全球市場細分依據資料、技術、包裝類型、服務類型、最終用戶、應用和地區。

管瓶包裝最常用於對無菌性有嚴格要求的藥品製劑，例如無菌注射劑、疫苗、生物製藥和冷凍乾燥產品。製藥企業採用玻璃和聚合物管瓶包裝藥品，因為它們具有很高的包裝完整性，並允許在儲存和分銷過程中對無菌性要求進行全面檢驗。 FDA、EMA 和 USP 第 1207 節日益嚴格的監管要求推動了對管瓶包裝系統完整性測試的迫切需求。注射劑、生物相似藥和抗癌藥物產量的持續成長也帶來了對管瓶包裝的強勁需求。鑑於真空衰減和高壓洩漏檢測 (HVLD) 等確定性測試技術的廣泛應用，預計此類產品將繼續保持其市場主導地位。

在製藥和生物製藥生產外包規模不斷擴大的推動下，合約研發生產力組織 (CDMO) 領域在容器和密封完整性測試 (CCIT) 市場中蘊藏著最大的機會。隨著 CDMO 擴大無菌注射、生物製藥、細胞療法和基因療法的生產，確保管瓶、注射器、藥筒和其他給藥系統包裝完整性的需求持續成長。日益嚴格的監管和更嚴苛的品質保證要求進一步加速了 CDMO 各機構對先進 CCIT 技術的應用。

容器和密封完整性測試市場—區域分析

北美容器密封完整性測試 (CCIT) 市場具有許多傳統優勢，例如先進的製藥生產基礎設施、精密的生物製藥生產、廣泛的成熟製藥生產設施網路以及嚴格的無菌藥品包裝監管要求。美國在推動 USP<1207> 確定性測試方法的應用方面發揮主導作用，並大力投資於注射劑的研發。

例如，2025年，美國食品藥物管理局（FDA）批准了來自不同公司的50種新產品，其中許多產品需要無菌檢驗包裝，並且在產品開發和商業化過程中必須經過CCIT（商業認證傳染性藥物）認證。美國FDA維護一個龐大的註冊製藥生產設施網路，為北美地區提供CCIT生產流程各階段所需的藥品。這使得北美市場對CCIT產品的需求持續旺盛，尤其是在製藥、生物技術和契約製造領域。

美國容器和密封完整性測試 (CCIT) 市場 - 國家/地區概況

由於美國在藥物研發和生技藥品生產方面投入巨資，以及美國食品藥物管理局 (FDA) 對無菌產品的嚴格監管，美國已成為美國包裝完整性檢測 (USCCIT) 市場中最大的單一市場。注射給藥系統、生技藥品和先進技術藥物開發平臺中藥物數量的不斷成長，持續推動可靠包裝完整性檢測的需求。例如，FDA 報告稱，2025 年將新藥認證，其中超過一半 (52%) 的適應症族群非常小。因此，許多新的注射藥物將需要檢驗的無菌包裝系統，並接受嚴格的容器和密封完整性檢驗。鑑於美國製造商預計將繼續增加對藥物製造和生物製藥生產的投資，基於先進包裝的確定性 CCIT 產品市場預計將繼續擴張。

目錄

第1章：容器密封測試市場概述

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章：容器密封測試的關鍵市場趨勢

  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 未來市場趨勢

第4章：貨櫃密封測試的產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長前景展望圖
  • 管理體制分析

第5章：容器密封測試市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章：容器密封測試市場趨勢

  • 2025年容器氣密測試市佔率分析
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

第7章 容器密封測試市場：依材料分類

  • 概述
    • 基於細分市場的市場佔有率分析：按材料分類
    • 玻璃
    • 塑膠/聚合物
    • 彈性體/橡膠帽
    • 其他

第8章 容器密封測試市場：依技術分類

  • 概述
    • 基於細分市場的市場佔有率分析：按技術分類
    • 真空衰減法（無損檢測）
    • 氦氣洩漏檢測
    • 高壓洩漏檢測（HVLD）
    • 基於雷射的頂空分析
    • 染料滲入
    • 微生物入侵
    • 超音波檢測
    • 其他

第9章 容器密封測試市場：依包裝類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按包裝類型
    • 管瓶
    • 預填充式注射器
    • 安瓿
    • 墨水匣
    • 輸液袋和輸液包
    • 吸塑包裝
    • 瓶子
    • 其他

第10章 容器密封測試市場：依服務類型分類

  • 概述
    • 基於細分市場的市場佔有率分析：按服務類型
    • 方法開發與驗證
    • 定期完整性測試
    • 支援穩定性測試
    • 監理合規諮詢
    • 缺陷調查

第11章 容器密封測試市場：依最終用戶分類

  • 概述
    • 基於細分市場的市場佔有率分析：按最終用戶分類
    • 製藥公司
    • 生技公司
    • 合約研發生產組織（CDMO）
    • 醫療設備製造商
    • 學術研究機構

第12章 容器密封測試市場：依應用領域分類

  • 概述
    • 基於細分市場的市場佔有率分析：按應用領域
    • 無菌產品的檢測
    • 凍乾產品的檢測
    • 液體藥物的檢測
    • 複合材料產品的測試

第13章 容器密封測試市場：按地區分類

  • 介紹
  • 北美洲
    • 概述
    • 主要製造商：北美
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 主要製造商：歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 丹麥
    • 其他歐洲國家
  • 亞太地區
    • 概述
    • 主要製造商：亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 台灣
    • 越南
    • 其他亞太國家
  • 拉丁美洲
    • 概述
    • 主要製造商：拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他拉丁美洲國家
  • 中東和非洲
    • 概述
    • 主要生產商：中東和非洲
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 伊朗
    • 卡達
    • 其他中東和非洲國家

第14章：主要供應商分析：容器密封測試產業

  • 競爭基準
    • 競爭對手儀錶板
    • 競爭定位
  • 公司簡介
    • Albany Molecular Research Inc.（AMRI）
    • Analytical Lab Group
    • Berkshire Sterile Manufacturing
    • Confarma
    • Cormica
    • Curia
    • DDL and Nelson Labs
    • Eurofins Scientific
    • Gateway Analytical
    • Genesis Packaging Technologies
    • Labcorp Drug Development
    • Lighthouse Instruments
    • Mocon, Inc.
    • Nelson Labs
    • Pfeiffer Vacuum
    • PTI（Packaging Technologies & Inspection）
    • Qualitest
    • SGS SA
    • Stevanato Group
    • Toxikon Corporation
    • West Pharmaceutical Services
    • WIL Research Laboratories
    • Wilco
    • Others

第15章：AnalystView 的全景視圖

簡介目錄
Product Code: ANV6822

Container Closure Integrity Testing Market size was valued at US$ 280.1 Million in 2025, expanding to a CAGR of 10.2% from 2026 to 2033.

The Container Closure Integrity Testing (CCIT) market comprises instruments, testing technologies, and validation services used to verify the integrity of pharmaceutical and biopharmaceutical packaging, ensuring sterile products remain free from leaks and contamination throughout their shelf life. Market growth is driven by stricter regulatory requirements, increasing production of injectable drugs and biologics, and a stronger focus on product quality and patient safety. Rising adoption of deterministic, non-destructive testing methods, automation, and advanced inspection systems is further accelerating demand. However, high equipment costs and complex validation requirements continue to limit broader market adoption.

Container Closure Integrity Testing Market- Market Dynamics

Rising Production of Sterile Injectable Drugs and Biologics

A large factor behind the growth of the CCIT Market is the rise in producing sterile injectable drugs, biologics, vaccines and advanced therapeutics. With the development of more sterile parenteral products, pharmacies are becoming increasingly mindful and diligent in ensuring container closure integrity for their products throughout each phase of their life cycle, to maintain sterility and prevent contamination with microbes or moisture from entering. Agencies like the U.S. Food and Drug Administration (FDA) and the United States Pharmacopeia (USP <1207>) have regulatory requirements for container closure integrity testing of sterile products. The result is a rapidly growing market for deterministic methods of CCIT. Global companies are currently manufacturing over 80 brands of CCIT technology and over 40 services specific to CCIT. The ongoing growth of biologics, prefilled syringes, drug injection therapies and more stringent regulations will continue to place an increased demand for advanced container closure integrity testing solutions.

Container Closure Integrity Testing Market- Segmentation Analysis:

The worldwide market is segmented based on Material, Technology, Packaging Type, Service Type, End-user, Application, and Region.

Vial's product type was most often used for drug formulations that required strict assurance, including sterile injectable drugs, vaccines and biologics and lyophilized products. Pharmaceutical manufacturers rely on glass and polymer vials for their drug formulation because they have a high degree of packaging integrity that can provide complete validation of the sterility requirement in both the storage and distribution process. Because of the increased regulatory requirements, such as those imposed by the FDA, EMA and USP Section 1207, there is an increased demand for robust integrity testing of vial packaging systems. The continuing increase in production of injectable therapy, biosimilar and oncology drugs is creating a robust demand for vial-based packaging. The same product type is expected to maintain its dominant position in the market because of widespread use of deterministic testing technologies such as vacuum decay and high-voltage leak detection (HVLD).

The Contract Development and Manufacturing Organizations (CDMOs) segment represents the largest opportunity for the container closure integrity testing (CCIT) market, driven by the growing outsourcing of pharmaceutical and biopharmaceutical manufacturing. As CDMOs expand production of sterile injectables, biologics, cell therapies, and gene therapies, the need to ensure packaging integrity for vials, syringes, cartridges, and other drug delivery systems continues to rise. Increasing regulatory scrutiny and quality assurance requirements are further accelerating the adoption of advanced CCIT technologies across CDMO facilities.

Container Closure Integrity Testing Market- Geographical Insights

The Container Closure Integrity Testing (CCIT) Market in North America has been characterized by its traditional strength of having an advanced pharmaceutical manufacturing infrastructure, sophisticated biologics production, an extensive network of established drug manufacturing facilities, and rigorous regulatory requirements related to the packaging of sterile drugs. The US has led the way in promoting the increased use of USP <1207> deterministic testing methods and injecting significant amounts into the development of injectable drugs.

For example, in 2025, the US Food and Drug Administration (FDA) issued approvals for 50 new products from a variety of companies, and many of these new drugs require packaging that is validated as sterile and undergo CCIT during product development and commercialization. The US FDA maintains an extensive network of registered drug manufacturing facilities supplying North America with pharmaceutical products at all stages of the CCIT manufacturing process. This has created continuous demand for CCIT products in the North American market, especially in pharmaceuticals, biotechnology, and contract manufacturers.

United States Container Closure Integrity Testing Market- Country Insights

The US represents the single greatest USCCIT market due to its significant investment in pharmaceutical R&D, manufacturing biologics and the FDA's regulation of sterile products. The increasing number of drugs in the pipeline for injectable delivery systems, biologics and advanced technologies continue to increase the need for reliable package integrity testing. In 2025, for example, the FDA reported the approval of 50 new drugs, but over half of them (52%) were for very few patients; so, many of the new injectable drugs must have validated sterile packaging systems that undergo rigorous container closure integrity validation. The anticipated continuation of US manufacturers investing in drug manufacturing and biologics production will continue to boost the market for advanced deterministic CCIT products.

Container Closure Integrity Testing Market- Competitive Landscape:

The Container Closure Integrity Testing (CCIT) market - competitive landscape is very competitive, as companies have made significant investments into technological innovation, meeting regulatory compliance and producing high-quality, highly-precise testing solutions for pharmaceutical and biotechnology industries. Companies compete based on accuracy of the tests they provide to customers, degree of automation of their products, and support capabilities (for both deterministic & non-destructive inspection).

Companies in the CCIT market frequently employ a variety of strategic initiatives to grow their market share and respond to the evolving needs of this industry through R&D investment, product introductions, and partnerships, as well as expansion into new markets globally. Examples of major players in the CCIT market that are utilizing cutting edge technology along with their global expertise include West Pharmaceutical Services, Inc., INFICON Holding AG, SP Scientific, Uson, L.P., and Shimadzu Corporation. These companies are utilizing leading edge technology to enhance their competitiveness and respond to the growing demands for quality assurance in the marketplace.

Recent Developments:

In May 2026, CS Analytical announced that its enhanced package distribution testing services have now completed their buildout and are fully operational. The enhancements are the result of a significant investment in state-of-the-art ASTM D4169-23 and ISTA testing capabilities, which will include a customized multimodal vibration/temperature/altitude simulation platform for validating packaging of pharmaceutical and medical device products.

In January 2026, Sharp Services disclosed that they are investing over €20 million for expanding their packaging capacity for injectables at their locations in both the Netherlands and Belgium. The new investment will include cold-chain storage, syringe assembly, blister packaging, and GMP production to accommodate the growing demand for injectable drug formats.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Albany Molecular Research Inc. (AMRI)
  • Analytical Lab Group
  • Berkshire Sterile Manufacturing
  • Confarma
  • Cormica
  • Curia
  • DDL and Nelson Labs
  • Eurofins Scientific
  • Gateway Analytical
  • Genesis Packaging Technologies
  • Labcorp Drug Development
  • Lighthouse Instruments
  • Mocon, Inc.
  • Nelson Labs
  • Pfeiffer Vacuum
  • PTI (Packaging Technologies & Inspection)
  • Qualitest
  • SGS SA
  • Stevanato Group
  • Toxikon Corporation
  • West Pharmaceutical Services
  • WIL Research Laboratories
  • Wilco
  • Others

GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY MATERIAL- MARKET ANALYSIS, 2020 - 2033

  • Glass
  • Plastic/Polymer
  • Elastomer/Rubber Closures
  • Others

GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2020 - 2033

  • Vacuum Decay (Non-destructive)
  • Helium Leak Detection
  • High Voltage Leak Detection (HVLD)
  • Laser-Based Headspace Analysis
  • Dye Ingress
  • Microbial Ingress
  • Ultrasound Detection
  • Others

GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY PACKAGING TYPE- MARKET ANALYSIS, 2020 - 2033

  • Vials
  • Pre-filled Syringes
  • Ampoules
  • Cartridges
  • IV Bags and Pouches
  • Blister Packs
  • Bottles
  • Others

GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY SERVICE TYPE- MARKET ANALYSIS, 2020 - 2033

  • Method Development & Validation
  • Routine Integrity Testing
  • Stability Testing Support
  • Regulatory Compliance Consulting
  • Failure Investigations

GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY APPLICATION- MARKET ANALYSIS, 2020 - 2033

  • Sterile Product Testing
  • Lyophilized Product Testing
  • Liquid Drug Product Testing
  • Combination Product Testing

GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2020 - 2033

  • Pharmaceutical Companies
  • Biotechnology Companies
  • Contract Development & Manufacturing Organizations (CDMOs)
  • Medical Device Companies
  • Academic & Research Institutes

GLOBAL CONTAINER CLOSURE INTEGRITY TESTING MARKET, BY REGION- MARKET ANALYSIS, 2020 - 2033

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Denmark
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Taiwan
  • Vietnam
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Iran
  • Qatar
  • Rest of MEA

Table of Contents

1. Container Closure Integrity Testing Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
  • 2.2. Competitive Insights

3. Container Closure Integrity Testing Key Market Trends

  • 3.1. Container Closure Integrity Testing Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Container Closure Integrity Testing Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Container Closure Integrity Testing Market Opportunities
  • 3.4. Container Closure Integrity Testing Market Future Trends

4. Container Closure Integrity Testing Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Container Closure Integrity Testing Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Container Closure Integrity Testing Market Landscape

  • 6.1. Container Closure Integrity Testing Market Share Analysis, 2025
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Container Closure Integrity Testing Market - By Material

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Material, 2025 & 2033 (%)
    • 7.1.2. Glass
    • 7.1.3. Plastic/Polymer
    • 7.1.4. Elastomer/Rubber Closures
    • 7.1.5. Others

8. Container Closure Integrity Testing Market - By Technology

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Technology, 2025 & 2033 (%)
    • 8.1.2. Vacuum Decay (Non-destructive)
    • 8.1.3. Helium Leak Detection
    • 8.1.4. High Voltage Leak Detection (HVLD)
    • 8.1.5. Laser-Based Headspace Analysis
    • 8.1.6. Dye Ingress
    • 8.1.7. Microbial Ingress
    • 8.1.8. Ultrasound Detection
    • 8.1.9. Others

9. Container Closure Integrity Testing Market - By Packaging Type

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Packaging Type, 2025 & 2033 (%)
    • 9.1.2. Vials
    • 9.1.3. Pre-filled Syringes
    • 9.1.4. Ampoules
    • 9.1.5. Cartridges
    • 9.1.6. IV Bags and Pouches
    • 9.1.7. Blister Packs
    • 9.1.8. Bottles
    • 9.1.9. Others

10. Container Closure Integrity Testing Market - By Service Type

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Service Type, 2025 & 2033 (%)
    • 10.1.2. Method Development & Validation
    • 10.1.3. Routine Integrity Testing
    • 10.1.4. Stability Testing Support
    • 10.1.5. Regulatory Compliance Consulting
    • 10.1.6. Failure Investigations

11. Container Closure Integrity Testing Market - By End-user

  • 11.1. Overview
    • 11.1.1. Segment Share Analysis, By End-user, 2025 & 2033 (%)
    • 11.1.2. Pharmaceutical Companies
    • 11.1.3. Biotechnology Companies
    • 11.1.4. Contract Development & Manufacturing Organizations (CDMOs)
    • 11.1.5. Medical Device Companies
    • 11.1.6. Academic & Research Institutes

12. Container Closure Integrity Testing Market - By Application

  • 12.1. Overview
    • 12.1.1. Segment Share Analysis, By Application, 2025 & 2033 (%)
    • 12.1.2. Sterile Product Testing
    • 12.1.3. Lyophilized Product Testing
    • 12.1.4. Liquid Drug Product Testing
    • 12.1.5. Combination Product Testing

13. Container Closure Integrity Testing Market- By Geography

  • 13.1. Introduction
    • 13.1.1. Segment Share Analysis, By Geography, 2025 & 2033 (%)
  • 13.2. North America
    • 13.2.1. Overview
    • 13.2.2. Container Closure Integrity Testing Key Manufacturers in North America
    • 13.2.3. North America Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 13.2.4. North America Market Size and Forecast, By Material, 2020 - 2033 (US$ Million)
    • 13.2.5. North America Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 13.2.6. North America Market Size and Forecast, By Packaging Type, 2020 - 2033 (US$ Million)
    • 13.2.7. North America Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
    • 13.2.8. North America Market Size and Forecast, By End-user, 2020 - 2033 (US$ Million)
    • 13.2.9. North America Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 13.2.10. U.S.
    • 13.2.11. Canada
  • 13.3. Europe
    • 13.3.1. Overview
    • 13.3.2. Container Closure Integrity Testing Key Manufacturers in Europe
    • 13.3.3. Europe Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 13.3.4. Europe Market Size and Forecast, By Material, 2020 - 2033 (US$ Million)
    • 13.3.5. Europe Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 13.3.6. Europe Market Size and Forecast, By Packaging Type, 2020 - 2033 (US$ Million)
    • 13.3.7. Europe Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
    • 13.3.8. Europe Market Size and Forecast, By End-user, 2020 - 2033 (US$ Million)
    • 13.3.9. Europe Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 13.3.10. Germany
    • 13.3.11. UK
    • 13.3.12. France
    • 13.3.13. Italy
    • 13.3.14. Spain
    • 13.3.15. The Netherlands
    • 13.3.16. Sweden
    • 13.3.17. Russia
    • 13.3.18. Poland
    • 13.3.19. Denmark
    • 13.3.20. Rest of Europe
  • 13.4. Asia Pacific (APAC)
    • 13.4.1. Overview
    • 13.4.2. Container Closure Integrity Testing Key Manufacturers in Asia Pacific
    • 13.4.3. APAC Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 13.4.4. Asia Pacific Market Size and Forecast, By Material, 2020 - 2033 (US$ Million)
    • 13.4.5. Asia Pacific Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 13.4.6. Asia Pacific Market Size and Forecast, By Packaging Type, 2020 - 2033 (US$ Million)
    • 13.4.7. Asia Pacific Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
    • 13.4.8. Asia Pacific Market Size and Forecast, By End-user, 2020 - 2033 (US$ Million)
    • 13.4.9. Asia Pacific Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 13.4.10. China
    • 13.4.11. India
    • 13.4.12. Japan
    • 13.4.13. South Korea
    • 13.4.14. Australia
    • 13.4.15. Indonesia
    • 13.4.16. Thailand
    • 13.4.17. Philippines
    • 13.4.18. Taiwan
    • 13.4.19. Vietnam
    • 13.4.20. Rest of APAC
  • 13.5. Latin America (LATAM)
    • 13.5.1. Overview
    • 13.5.2. Container Closure Integrity Testing Key Manufacturers in Latin America
    • 13.5.3. LATAM Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 13.5.4. LATAM Market Size and Forecast, By Material, 2020 - 2033 (US$ Million)
    • 13.5.5. LATAM Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 13.5.6. LATAM Market Size and Forecast, By Packaging Type, 2020 - 2033 (US$ Million)
    • 13.5.7. LATAM Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
    • 13.5.8. LATAM Market Size and Forecast, By End-user, 2020 - 2033 (US$ Million)
    • 13.5.9. LATAM Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 13.5.10. Brazil
    • 13.5.11. Mexico
    • 13.5.12. Argentina
    • 13.5.13. Colombia
    • 13.5.14. Rest of LATAM
  • 13.6. Middle East and Africa (MEA)
    • 13.6.1. Overview
    • 13.6.2. Container Closure Integrity Testing Key Manufacturers in Middle East and Africa
    • 13.6.3. MEA Market Size and Forecast, By Country, 2020 - 2033 (US$ Million)
    • 13.6.4. MEA Market Size and Forecast, By Material, 2020 - 2033 (US$ Million)
    • 13.6.5. MEA Market Size and Forecast, By Technology, 2020 - 2033 (US$ Million)
    • 13.6.6. MEA Market Size and Forecast, By Packaging Type, 2020 - 2033 (US$ Million)
    • 13.6.7. MEA Market Size and Forecast, By Service Type, 2020 - 2033 (US$ Million)
    • 13.6.8. MEA Market Size and Forecast, By End-user, 2020 - 2033 (US$ Million)
    • 13.6.9. MEA Market Size and Forecast, By Application, 2020 - 2033 (US$ Million)
    • 13.6.10. Saudi Arabia
    • 13.6.11. UAE
    • 13.6.12. Israel
    • 13.6.13. Turkey
    • 13.6.14. Algeria
    • 13.6.15. Egypt
    • 13.6.16. Iran
    • 13.6.17. Qatar
    • 13.6.18. Rest of MEA

14. Key Vendor Analysis- Container Closure Integrity Testing Industry

  • 14.1. Competitive Benchmarking
    • 14.1.1. Competitive Dashboard
    • 14.1.2. Competitive Positioning
  • 14.2. Company Profiles
    • 14.2.1. Albany Molecular Research Inc. (AMRI)
    • 14.2.2. Analytical Lab Group
    • 14.2.3. Berkshire Sterile Manufacturing
    • 14.2.4. Confarma
    • 14.2.5. Cormica
    • 14.2.6. Curia
    • 14.2.7. DDL and Nelson Labs
    • 14.2.8. Eurofins Scientific
    • 14.2.9. Gateway Analytical
    • 14.2.10. Genesis Packaging Technologies
    • 14.2.11. Labcorp Drug Development
    • 14.2.12. Lighthouse Instruments
    • 14.2.13. Mocon, Inc.
    • 14.2.14. Nelson Labs
    • 14.2.15. Pfeiffer Vacuum
    • 14.2.16. PTI (Packaging Technologies & Inspection)
    • 14.2.17. Qualitest
    • 14.2.18. SGS SA
    • 14.2.19. Stevanato Group
    • 14.2.20. Toxikon Corporation
    • 14.2.21. West Pharmaceutical Services
    • 14.2.22. WIL Research Laboratories
    • 14.2.23. Wilco
    • 14.2.24. Others

15. 360 Degree Analyst View

16. Appendix

  • 16.1. Research Methodology
  • 16.2. References
  • 16.3. Abbreviations
  • 16.4. Disclaimer
  • 16.5. Contact Us